Page last updated: 2024-08-23

stiripentol and cannabidiol

stiripentol has been researched along with cannabidiol in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (22.22)	24.3611
2020's	7 (77.78)	2.80

Authors

Authors	Studies
Andrade, DM; Arzimanoglou, A; Camfield, CS; Camfield, PR; Chiron, C; Cramer, JA; French, JA; Kossoff, E; Mula, M; Nabbout, R	1
Blakey, G; Crockett, J; Morrison, G; Sommerville, K	1
Perry, MS	1
Samanta, D	1
Fulton, SP; Mudigoudar, BD; Wheless, JW	1
Arenas Cabrera, CM; Ben-Menachem, E; Critchley, D; Crockett, J; Gunning, B; Morrison, G; Tayo, B; Toledo, M; VanLandingham, K; Wray, L	1
Critchley, D; Gidal, B; Morrison, G; Patsalos, PN; Szaflarski, JP; VanLandingham, K	1
García-Peñas, JJ; Gil Nagel-Rein, A; Sánchez-Carpintero, R; Villanueva-Haba, V	1

Reviews

7 review(s) available for stiripentol and cannabidiol

Article	Year
Treatment issues for children with epilepsy transitioning to adult care. Epilepsy & behavior : E&B, 2017, Volume: 69 Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Cannabidiol; Child; Congresses as Topic; Diet, Ketogenic; Dioxolanes; Epilepsy; Humans; Transition to Adult Care; Treatment Outcome; Vigabatrin; Young Adult	2017
New and Emerging Medications for Treatment of Pediatric Epilepsy. Pediatric neurology, 2020, Volume: 107 Topics: Anticonvulsants; Cannabidiol; Child; Dioxolanes; Epilepsy; Fenfluramine; Humans; Piperidines; Pregnanolone; Pyridines	2020
Changing Landscape of Dravet Syndrome Management: An Overview. Neuropediatrics, 2020, Volume: 51, Issue:2 Topics: Anticonvulsants; Cannabidiol; Dioxolanes; Epilepsies, Myoclonic; Fenfluramine; Genetic Therapy; Humans; Oligonucleotides, Antisense	2020
Dravet Syndrome: A Review of Current Management. Pediatric neurology, 2020, Volume: 107 Topics: Anticonvulsants; Cannabidiol; Child; Dioxolanes; Epilepsies, Myoclonic; Fenfluramine; Genetic Testing; Humans	2020
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs. Epilepsia, 2020, Volume: 61, Issue:9 Topics: Anticonvulsants; Cannabidiol; Clinical Trials as Topic; Clobazam; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Dioxolanes; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; Fatty Acids, Monounsaturated; Humans; Lennox Gastaut Syndrome; Valproic Acid	2020
Stiripentol (Diacomit) for Dravet syndrome. The Medical letter on drugs and therapeutics, 2021, 03-22, Volume: 63, Issue:1620 Topics: Adolescent; Anticonvulsants; Cannabidiol; Child; Child, Preschool; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inducers; Dioxolanes; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans	2021
Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain. Revista de neurologia, 2021, 09-10, Volume: 73, Issue:S01 Topics: Anticonvulsants; Cannabidiol; Clobazam; Clonazepam; Diazepam; Dioxolanes; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Phenobarbital; Practice Guidelines as Topic; Pyrrolidinones; Spain; Triazoles; Valproic Acid	2021

Trials

2 trial(s) available for stiripentol and cannabidiol

Article	Year
A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects. Clinical pharmacology in drug development, 2019, Volume: 8, Issue:8 Topics: Adult; Anticonvulsants; Cannabidiol; Clobazam; Cytochrome P-450 CYP2C19; Dioxolanes; Drug Interactions; Female; Genotype; Healthy Volunteers; Humans; Male; Valproic Acid	2019
A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy. CNS drugs, 2020, Volume: 34, Issue:6 Topics: Adolescent; Adult; Anticonvulsants; Area Under Curve; Cannabidiol; Dioxolanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Valproic Acid; Young Adult	2020

Article

Year

A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects.

Clinical pharmacology in drug development, 2019, Volume: 8, Issue:8

Topics: Adult; Anticonvulsants; Cannabidiol; Clobazam; Cytochrome P-450 CYP2C19; Dioxolanes; Drug Interactions; Female; Genotype; Healthy Volunteers; Humans; Male; Valproic Acid

2019

A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy.

CNS drugs, 2020, Volume: 34, Issue:6

Topics: Adolescent; Adult; Anticonvulsants; Area Under Curve; Cannabidiol; Dioxolanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Valproic Acid; Young Adult

2020